NISA INVESTMENT ADVISORS, LLC

Position in OABI — OmniAb, Inc.

CIK 937615 ST. LOUIS, MO

Position in OABI

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,279

+$510 QoQ

Shares Held

520

+6.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#110

of 141 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. OABI ranks #229 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,279	520	+6.1%	Shares	Sole	2026-08-10
2026-03-31	$769	490	0.0%	Shares	Sole	2026-04-30
2025-12-31	$906	490	-90.4%	Shares	Sole	2026-01-15
2025-09-30	$8,180	5,113	0.0%	Shares	Sole	2025-10-23
2025-06-30	$8,896	5,113	+100.2%	Shares	Sole	2025-07-31
2025-03-31	$6,129	2,554	-11.2%	Shares	Sole	2025-04-30
2024-12-31	$10,184	2,877	+8.1%	Shares	Sole	2025-01-17
2024-09-30	$11,260	2,662	+0.0%	Shares	Sole	2024-10-24
2024-06-30	$9,978	2,661	-3.3%	Shares	Sole	2024-07-19
2024-03-31	$14,915	2,752	+4.9%	Shares	Sole	2024-05-02
2023-12-31	$16,183	2,623	+2.7%	Shares	Sole	2024-01-25
2023-09-30	$13,255	2,554	0.0%	Shares	Sole	2023-11-02
2023-06-30	$12,846	2,554	+243.3%	Shares	Sole	2023-08-11
2023-03-31	$2,737	744	0.0%	Shares	Sole	2023-05-02
2022-12-31	$3	744	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.